Goodwin Procter advised HOOKIPA, and Duane Morris advised the underwriters involved in the offering. HOOKIPA Pharma Inc. (Nasdaq: HOOK) announced its underwritten public offering of 22,900,768...
HOOKIPA Pharma’s $50 Million Public Offering of Common Stock and Convertible Preferred Stock
HOOKIPA Pharma’s Collaboration and Licensing Agreement with Roche
Squire Patton Boggs has advised HOOKIPA Pharma on the deal. HOOKIPA Pharma Inc (NASDAQ: HOOK), a company developing a new class of immunotherapies based on its...